Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -61,500 | -59,600 | -1,500 | -53,430 |
| Depreciation Amortization | N/A | 6,060 | 4,260 | 2,130 | 64,800 |
| Other Working Capital | N/A | 3,920 | 960 | -380 | -410 |
| Other Operating Activity | 0 | 59,330 | 58,440 | 1,790 | -1,510 |
| Operating Cash Flow | $N/A | $7,810 | $4,060 | $2,040 | $9,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1,720 | -1,260 | -380 | -1,660 |
| Other Investing Activity | 0 | -17,700 | 6,450 | -510 | -5,350 |
| Investing Cash Flow | $N/A | $-19,420 | $5,190 | $-890 | $-7,010 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 2,670 | 2,980 | 1,440 | 5,980 |
| Financing Cash Flow | $N/A | $2,670 | $2,980 | $1,440 | $5,980 |
| Exchange Rate Effect | N/A | 20 | 40 | -10 | -70 |
| Beginning Cash Position | N/A | 38,960 | 38,960 | 38,960 | 30,600 |
| End Cash Position | N/A | 30,060 | 51,250 | 41,540 | 38,960 |
| Net Cash Flow | $N/A | $-8,900 | $12,280 | $2,580 | $8,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 7,810 | 4,060 | 2,040 | 9,450 |
| Free Cash Flow | 0 | 7,810 | 4,060 | 2,040 | 9,450 |